Gonadotropin-releasing hormone agonist (GnRH agonist) daily luteal support
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gonadotropin-releasing hormone agonist (GnRH agonist) daily luteal support, covering 2021-12-03 to 2021-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a [Phase 2]